Skip to content

Research at St Andrews

The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations

Research output: Contribution to journalArticle

DOI

Open Access permissions

Open

Author(s)

Ruth Bowness, Martin J Boeree, Rob Aarnoutse, Rodney Dawson, Andreas Diacon, Chacha Mangu, Norbert Heinrich, Nyanda E Ntinginya, Anke Kohlenberg, Bariki Mtafya, Patrick P J Phillips, Andrea Rachow, Georgette Plemper van Balen, Stephen H Gillespie

School/Research organisations

Abstract

Objectives The relationship between cfu and Mycobacterial Growth Indicator Tube (MGIT) time to positivity (TTP) is uncertain. We attempted to understand this relationship and create a mathematical model to relate these two methods of determining mycobacterial load.

Close

Details

Original languageEnglish
Pages (from-to)448-455
Number of pages8
JournalJournal of Antimicrobial Chemotherapy
Volume70
Issue number2
Early online date25 Oct 2014
DOIs
StatePublished - Feb 2015

    Research areas

  • TTP, M, Tuberculosis, TB

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Project Sanitarium: playing tuberculosis to its end game

    Donald, I., Meyer, K., Brengman, J., Gillespie, S. H. & Bowness, R. Dec 2017 In : Journal of Computing in Higher Education. 29, 3, p. 599-617 19 p.

    Research output: Contribution to journalArticle

  2. Project Sanitarium: gaming TB - A serious game for a serious problem

    Donald, I., Meyer, K., Gillespie, S. H., Bowness, R. & Brengman, J. 16 Sep 2015 7th International Conference on Games and Virtual Worlds for Serious Applications, VS-Games 2015. IEEE, 8 p. 7295782

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  3. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study

    Tweed, C. D., Crook, A. M., Amukoye, E. I., Dawson, R., Diacon, A. H., Hanekom, M., McHugh, T. D., Mendel, C. M., Meredith, S. K., Murphy, M. E., Murthy, S. E., Nunn, A. J., Phillips, P. P. J., Singh, K. P., Spigelman, M., Wills, G. H. & Gillespie, S. H. 11 Jul 2018 In : BMC Infectious Diseases. 18, 11 p., 317

    Research output: Contribution to journalArticle

  4. Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: in the Cornell mouse model

    Liu, Y., Pertinez, H., Davies, G. R., Gillespie, S. H., Coates, A. R. & Hu, Y. Jul 2018 In : Antimicrobial Agents and Chemotherapy. 62, 7, 9 p., e00190-18

    Research output: Contribution to journalArticle

Related by journal

  1. Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation

    Millard, J., Pertinez, H., Bonnett, L., Model, E. M., Dartois, V., Johnson, J. L., Caws, M., Tiberi, S., Bolhuis, M., Alffenaar, J-W. C., Davies, G. & Sloan, D. J. 23 Mar 2018 In : Journal of Antimicrobial Chemotherapy. 73, 7, p. 1755-1762 8 p.

    Research output: Contribution to journalArticle

  2. Has primary care antimicrobial use really been increasing? Comparison of changes in different prescribing measures for a complete geographic population 1995–2014

    Neilly, M. D. J., Guthrie, B., Hernandez Santiago, V., Vadiveloo, T., Donnan, P. T. & Marwick, C. A. 1 Oct 2017 In : Journal of Antimicrobial Chemotherapy. 72, 10, p. 2921-2930 10 p.

    Research output: Contribution to journalArticle

  3. Improved power for TB phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods

    Svensson, R. J., Gillespie, S. H. & Simonsson, U. S. H. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2311-2319 9 p.

    Research output: Contribution to journalArticle

  4. ST3268: a geographically widespread primate MRSA clone

    Hsu, L-Y., Holden, M. T. G., Koh, T. H., Pettigrew, K. A., Cao, D., Hon, P. Y., Sergio, D. M., Pena, E. & Ogden, B. E. 1 Aug 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2401-2403 2 p.

    Research output: Contribution to journalLetter

  5. Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients

    Heinrich, N., Dawson, R., du Bois, J., Narunsky, K., Horwith, G., Phipps, A. J., Nacy, C. A., Aarnoutse, R. E., Boeree, M. J., Gillespie, S. H., Venter, A., Henne, S., Rachow, A., Phillips, P. P. J., Hoelscher, M., Diacon, A. H. & on behalf of the Pan African Consortium for the Evaluation of Antituberculosis Antibiotics (PanACEA) 27 Jan 2015 In : Journal of Antimicrobial Chemotherapy.

    Research output: Contribution to journalArticle

ID: 157165058